|
1
|
Jemal A, Clegg LX, Ward E, Ries LA, Wu X,
Jamison PM, Wingo PA, Howe HL, Anderson RN and Edwards BK: Annual
report to the nation on the status of cancer, 1975–2001, with a
special feature regarding survival. Cancer. 101:3–27. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. Ca: Cancer J Clin. 65:5–29. 2015.
|
|
3
|
Weinberg RA: pRb and Control of the Cell
Cycle Clock In: The Biology of Cancer. 2nd edition. Garland
Science; New York, NY: pp. 275–329. 2014
|
|
4
|
Liggett WH Jr and Sidransky D: Role of the
p16 tumor suppressor gene in cancer. J Clin Oncol. 16:1197–1206.
1998.PubMed/NCBI
|
|
5
|
Attri J, Srinivasan R, Majumdar S, Radotra
BD and Wig J: Alterations of tumor suppressor gene p16INK4a in
pancreatic ductal carcinoma. BMC Gastroenterol. 5:222005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuen PW, Man M, Lam KY and Kwong YL:
Clinicopathological significance of p16 gene expression in the
surgical treatment of head and neck squamous cell carcinomas. J
Clin Pathol. 55:58–60. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kalfert D, Celakovsky P, Laco J and
Ludvikova M: The role of protein p16 (INK4a) in glottic laryngeal
squamous cell carcinoma. Pathol Oncol Res. 20:909–915. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Craig C, Kim M, Ohri E, Wersto R, Katayose
D, Li Z, Choi YH, Mudahar B, Srivastava S, Seth P and Cowan K:
Effects of adenovirus-mediated p16INK4A expression on cell cycle
arrest are determined by endogenous p16 and Rb status in human
cancer cells. Oncogene. 16:265–272. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Piao CQ, Zhao YL and Hei TK: Analysis of
p16 and p21 (Cip1) expression in tumorigenic human bronchial
epithelial cells induced by asbestos. Oncogene. 20:7301–7306. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Zhu J, Man Z, Ao Y and Chen H:
Investigation on the structure and upconversion fluorescence of
Yb3+/Ho3+ co-doped fluorapatite crystals for
potential biomedical applications. Sci Rep. 4:44462014.
|
|
11
|
Ma J, He X, Wang W, Huang Y, Chen L, Cong
W, Gu J, Hu H, Shi J, Li L and Su C: E2F promoter-regulated
oncolytic adenovirus with p16 gene induces cell apoptosis and
exerts antitumor effect on gastric cancer. Dig Dis Sci.
54:1425–1431. 2009. View Article : Google Scholar
|
|
12
|
Chintala SK, Fueyo J, Gomez-Manzano C,
Venkaiah B, Bjerkvig R, Yung WK, Sawaya R, Kyritsis AP and Rao JS:
Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma
invasion in vitro. Oncogene. 15:2049–2057. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Knight BB, Oprea-Ilies GM, Nagalingam A,
Yang L, Cohen C, Saxena NK and Sharma D: Survivin upregulation,
dependent on leptin-EGFR-Notch1 axis, is essential for
leptin-induced migration of breast carcinoma cells. Endocr Relat
Cancer. 18:413–428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408
|
|
15
|
Huang YP, Lin IJ, Chen CC, Hsu YC, Chang
CC and Lee MJ: Delivery of small interfering RNAs in human cervical
cancer cells by polyethylenimine-functionalized carbon nanotubes.
Nanoscale Res Lett. 8:2672013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Neill CJ and McCluggage WG: p16
expression in the female genital tract and its value in diagnosis.
Adv Anat Pathol. 13:8–15. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Villacañas O, Pérez JJ and Rubio-Martínez
J: Structural analysis of the inhibition of Cdk4 and Cdk6 by p16
(INK4a) through molecular dynamics simulations. J Biomol Struct
Dyn. 20:347–358. 2002. View Article : Google Scholar
|
|
18
|
Nalabothula N, Lakka SS, Dinh DH, Gujrati
M, Olivero WC and Rao JS: Sense p16 and antisense uPAR bicistronic
construct inhibits angiogenesis and induces glioma cell death. Int
J Oncol. 30:669–678. 2007.PubMed/NCBI
|
|
19
|
Straume O, Sviland L and Akslen LA: Loss
of nuclear p16 protein expression correlates with increased tumor
cell proliferation (Ki-67) and poor prognosis in patients with
vertical growth phase melanoma. Clin Cancer Res. 6:1845–1853.
2000.PubMed/NCBI
|
|
20
|
Liang J, Wang P, Xie S, Wang W, Zhou X, Hu
J, Shi Q, Zhang X and Yu R: Bmi-1 regulates the migration and
invasion of glioma cells through p16. Cell Biol Int. 39:283–290.
2015. View Article : Google Scholar
|
|
21
|
Maurizi M, Almadori G, Ferrandina G,
Distefano M, Romanini ME, Cadoni G, Benedetti-Panici P, Paludetti
G, Scambia G and Mancuso S: Prognostic significance of epidermal
growth factor receptor in laryngeal squamous cell carcinoma. Br J
Cancer. 74:1253–1257. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lionello M, Lovato A, Staffieri A,
Blandamura S, Turato C, Giacomelli L, Staffieri C and Marioni G:
The EGFR-mTOR pathway and laryngeal cancer angiogenesis. Eur Arch
Otorhinolaryngol. 271:757–764. 2014. View Article : Google Scholar
|
|
23
|
Fukuda S and Pelus LM: Survivin, a cancer
target with an emerging role in normal adult tissues. Mol Cancer
Ther. 5:1087–1098. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Alao JP: The regulation of cyclin D1
degradation: Roles in cancer development and the potential for
therapeutic invention. Mol Cancer. 6:242007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Papadimitrakopoulou V, Izzo JG, Liu DD,
Myers J, Ceron TL, Lewin J, William WN Jr, Atwell A, Lee JJ,
Gillenwater A, et al: Cyclin D1 and cancer development in laryngeal
premalignancy patients. Cancer Prev Res (Phila). 2:14–21. 2009.
View Article : Google Scholar
|
